uso de insulina de ação ultra rápida

"uso de insulina de ação ul trarrápida". descritos aqui são métodos aprimorados de tratar hiperglicemia com uma combinação de uma insulina de ação ultrarrápida e insulina glargina compreendendo a administração prandial da insulina ultrarrápida, e administração de uma primeira dose de insul...

Full description

Saved in:
Bibliographic Details
Main Authors Campbell Howard, Peter Richardson, Robert A. Baughman, Richard Petrucci, Elizabeth Potocka, ANDERS HASAGER BOSS, ALFRED MANN
Format Patent
LanguagePortuguese
Published 11.06.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract "uso de insulina de ação ul trarrápida". descritos aqui são métodos aprimorados de tratar hiperglicemia com uma combinação de uma insulina de ação ultrarrápida e insulina glargina compreendendo a administração prandial da insulina ultrarrápida, e administração de uma primeira dose de insulina glargina dentro de 6 horas de vigília por dia. Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
AbstractList "uso de insulina de ação ul trarrápida". descritos aqui são métodos aprimorados de tratar hiperglicemia com uma combinação de uma insulina de ação ultrarrápida e insulina glargina compreendendo a administração prandial da insulina ultrarrápida, e administração de uma primeira dose de insulina glargina dentro de 6 horas de vigília por dia. Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Author Peter Richardson
Robert A. Baughman
ALFRED MANN
Campbell Howard
ANDERS HASAGER BOSS
Elizabeth Potocka
Richard Petrucci
Author_xml – fullname: Campbell Howard
– fullname: Peter Richardson
– fullname: Robert A. Baughman
– fullname: Richard Petrucci
– fullname: Elizabeth Potocka
– fullname: ANDERS HASAGER BOSS
– fullname: ALFRED MANN
BookMark eNrjYmDJy89L5WRQLy3OV0hJVcjMKy7NycxLBLETDy8_vDhfoTSnpChRoejwwoLMlEQeBta0xJziVF4ozc2g5OYa4uyhm1qQH59aXJCYnJqXWhLvFBTgaWBpaG5qbOpoYUyUIgB2BSv6
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID BRPI0917535A8
GroupedDBID EVB
ID FETCH-epo_espacenet_BRPI0917535A83
IEDL.DBID EVB
IngestDate Fri Jul 19 12:47:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Portuguese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_BRPI0917535A83
Notes Application Number: BR2009PI17535
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190611&DB=EPODOC&CC=BR&NR=PI0917535A8
ParticipantIDs epo_espacenet_BRPI0917535A8
PublicationCentury 2000
PublicationDate 20190611
PublicationDateYYYYMMDD 2019-06-11
PublicationDate_xml – month: 06
  year: 2019
  text: 20190611
  day: 11
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies MANNKIND CORPORATION
RelatedCompanies_xml – name: MANNKIND CORPORATION
Score 3.0642488
Snippet "uso de insulina de ação ul trarrápida". descritos aqui são métodos aprimorados de tratar hiperglicemia com uma combinação de uma insulina de ação ultrarrápida...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title uso de insulina de ação ultra rápida
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190611&DB=EPODOC&locale=&CC=BR&NR=PI0917535A8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAdbplonADK0LLPcMdE2M09J0k8ySLXUNU00M0ywsLRItwYc9-_qZeYSaeEWYRjAxZMP2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1aO8YWLuZAfOui5Ota4C_i7-zmrOzrVOQml-QbYAnsGIENs1NHS2YGViB7WhzUHZwDXMCbUspQK5T3AQZ2AKAxuWVCDEwFZQIM3A6w65eE2bg8IXOeAOZ0MxXLMKgXlqcr5CSqgBdPp4IYiceXn54cb5CaU5JUaJC0eGFBZkpiaIMSm6uIc4eukAb4-H-i3cKQnKdsRgDC7DjnyrBoJBomGIB6h6ZmqUCG_3mSUmJqZbAzmNaSnKaqaWZiYUkgzQeg6TwykozcIGCC7ToydBQhoGlpKg0VRZYvZYkyYGDBQCXcn_B
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAdbplonADK0LLPcMdE2M09J0k8ySLXUNU00M0ywsLRItwYc9-_qZeYSaeEWYRjAxZMP2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1aO8YWLuZAfOui5Ota4C_i7-zmrOzrVOQml-QbYAnsGIENs1NHS2YGViBbWxzUHZwDXMCbUspQK5T3AQZ2AKAxuWVCDEwFZQIM3A6w65eE2bg8IXOeAOZ0MxXLMKgXlqcr5CSqgBdPp4IYiceXn54cb5CaU5JUaJC0eGFBZkpiaIMSm6uIc4eukAb4-H-i3cKQnKdsRgDC7DjnyrBoJBomGIB6h6ZmqUCG_3mSUmJqZbAzmNaSnKaqaWZiYUkgzQeg6TwysozcHqE-PrE-3j6eUszcIGCDrQAytBQhoGlpKg0VRZY1ZYkyYGDCADABYK0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=uso+de+insulina+de+a%C3%A7%C3%A3o+ultra+r%C3%A1pida&rft.inventor=Campbell+Howard&rft.inventor=Peter+Richardson&rft.inventor=Robert+A.+Baughman&rft.inventor=Richard+Petrucci&rft.inventor=Elizabeth+Potocka&rft.inventor=ANDERS+HASAGER+BOSS&rft.inventor=ALFRED+MANN&rft.date=2019-06-11&rft.externalDBID=A8&rft.externalDocID=BRPI0917535A8